0001209191-17-037920.txt : 20170605
0001209191-17-037920.hdr.sgml : 20170605
20170605180348
ACCESSION NUMBER: 0001209191-17-037920
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170602
FILED AS OF DATE: 20170605
DATE AS OF CHANGE: 20170605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17892465
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2017-06-02
4
M
0
22500
53.85
A
312142
D
Common Stock
2017-06-02
4
M
0
124601
29.98
A
436743
D
Common Stock
2017-06-02
4
S
0
147101
129.50
D
289642
D
Common Stock
440
I
401(k)
Stock Option (Right to Buy)
53.85
2017-06-02
4
M
0
22500
0.00
D
2021-05-31
Common Stock
22500
0
D
Stock Option (Right to Buy)
29.98
2017-06-02
4
M
0
124601
0.00
D
2021-12-13
Common Stock
124601
0
D
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Fully vested.
Omar White, Attorney-In-Fact
2017-06-05